Single Use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred Tank, Wave Induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User—Global Forecast to 2030

Single Use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred Tank, Wave Induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User—Global Forecast to 2030

Single Use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred Tank, Wave Induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User—Global Forecast to 2030

The single-use bioreactors market is projected to reach $10.3 billion by 2030, at a CAGR of 15.8% from 2023–2030.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, challenges, and opportunities. The growth in the single-use bioreactors market is mainly attributed to the rapid adoption of disposable technology in the pharmaceutical and biotechnology industry, growing demand for biopharmaceuticals, and capacity expansion of biopharmaceutical plants. In addition to this, emerging economies and the rising adoption of personalized medicine are likely to offer opportunities for market growth.

Based on type, in 2023, the stirred-tank bioreactors segment is expected to account for the largest share of the single-use bioreactors market. The large market share of this segment is attributed to the higher adoption of stirred-tank bioreactors compared to others and their advantages like short mixing time & high oxygen transfer rates.

Based on application, the commercial bioproduction segment is projected to register the highest CAGR over the forecast period. Large consumption of bioprocessing products in commercial production to meet the present and growing demand for biopharmaceutical products are expected to support the growth of this segment.

An in-depth analysis of the geographical scenario of the single-use bioreactors market provides detailed qualitative and quantitative insights into five major geographies {North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Ireland, Denmark, Belgium, and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and the Rest of Asia-Pacific), Latin America, and Middle East & Africa} along with the coverage of major countries in each region.

Based on geography, in 2023, Europe is expected to account for the largest share of this market. The growth of this market is driven by the increasing sales of drugs, support from government and regulatory authorities to promote the use of biopharmaceuticals for various health indications, and various companies expanding their manufacturing capacities as well as their operations. Some of the key players operating in the global single-use bioreactors market are Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.) CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Distek, Inc. (U.S.), and Infors AG (Switzerland).

Scope of the Report:

Global Single-use Bioreactors Market, by Product

Single-use Bioreactor Systems
Upto 10L
11L-500L
501-1000L
Above 1001L
Media Bags
2D
3D
Linear
Filtration Assemblies
Others

Note: Other products include pumps, single-use vessels, tubing & connectors, gas component, rocker, cable, sensors/probes, and film.

Global Single-use Bioreactors Market, by Type

Stirred-tank Bioreactors
Wave-induced Bioreactors
Others

Note: Other types of bioreactors include hybrid bioreactors, bubble-column, and bioreactors with vertically perforated discs.

Global Single-use Bioreactors Market, by Cell Type

Mammalian cells
Bacterial Cells
Yeast Cells
Others

Note: Other cell types include plant cells and insect cells.

Global Single-use Bioreactors Market, by Application

Commercial Bioproduction
Monoclonal Antibody Production
Vaccine Production
Therapeutic Protein Production
Cell & Gene Therapy
Research Bioproduction

Global Single-use Bioreactors Market, by End User

Pharmaceutical and Biopharmaceutical Companies
Contract Development and Manufacturing Organizations (CDMO) and Contract Research Organizations (CROs)
Academic & Research Institutes

Global Single-use Bioreactors Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Switzerland
Ireland
Denmark
Belgium
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
Japan
India
South Korea
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa

Single Use Bioreactors Market - Report Summary

Report Metrics	Details
Years Considered	2020 - 2030
Base Year	2022
Forecast Period	2023-2030
Page Count	251
Units Referenced	Value (USD Million)
Segments/Key Topics	Market by Product, Type, Cell Type, Application, and End User
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Key Companies Mentioned	Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), Solaris Biotechnology Srl (Italy), Cellexus International Ltd. (U.K.), CESCO Bioengineering Co., Ltd. (Taiwan), Distek, Inc. (U.S.), and Infors AG (Switzerland)

FAQs About the Report

What is the focus of the Single-use Bioreactors Market study?

This study offers a detailed assessment of the single-use bioreactors market, including the market size & forecast for various segmentations such as product, type, cell type, application, and end user. The single-use bioreactors market study also involves the value analysis of various segments of single-use bioreactors at regional and country levels.

What is the value of revenue generated from selling single-use bioreactors across the globe? At what rate is their demand expected to grow for the next 5-7 years?

The global single-use bioreactors market is projected to reach $10.3 billion by 2030, at a CAGR of 15.8% during the forecast period.

Which product segment is estimated to hold the major share and register the highest growth rate in the single-use bioreactors market?

In 2023, the single-use bioreactor systems segment is expected to account for the largest share of the single-use bioreactors market. The increased use of single-use technology due to its advantages, such as reduced cleaning requirements and carbon footprint, less capital requirement, more flexibility, reduced risk of cross-contamination, and focus of vendors on large-scale biomanufacturing, contribute to this segment's large market share. However, the media bags segment is expected to grow at the highest rate in the coming years.

Which type segment is projected to register the highest CAGR during the forecast period?

In 2023, the wave-induced bioreactors segment is projected to register the highest CAGR over the forecast period. The advantages offered by these bioreactors over stirred-tank and increasing cell-based research supported the adoption are the key factors supporting market growth.

What are the key factors supporting the growth of this market? Also, what are the major opportunities for existing market players and new entrants in the global single-use bioreactor market?

The growth of this market is driven by the growing adoption of disposable technologies in the pharmaceutical and biotechnology industries, capacity expansions of biopharmaceutical plants, rising pharmaceutical R&D expenditures, the growing adoption of biosimilars, and the increasing prevalence of chronic diseases. Moreover, emerging economies and the increasing adoption of personalized medicines offer significant opportunities for the players operating in this market.

Who are the major players operating in the single-use bioreactor market?

Merck KGaA (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Solaris Biotechnology srl (Italy), Cellexus International Ltd. (U.K.) CESCO Bioengineering Co., Ltd. (Taiwan), PBS Biotech, Inc. (U.S.), Distek, Inc. (U.S.), and Infors AG (Switzerland).

Which regions/countries are expected to offer significant growth opportunities for the market players operating in the global single-use bioreactors market?

Emerging economies in Asia-Pacific are projected to offer significant growth opportunities to the market players due to the increasing disposable income and rising foreign direct investments (FDI) for pharmaceuticals and biopharmaceutical companies, driving the market growth in this market.